TRANSGENE BIOTEK LTD.
Market Cap.(`)
|
48.87 Cr.
|
P/BV
|
4.56
|
Book Value (`)
|
1.41
|
52 Week High/Low ( ` )
|
12/6
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Book Closure
|
05/12/2024
|
EPS (`)
|
0.00
|
Div Yield (%)
|
0.00
|
You can view the
Consolidated
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -0.09 | -0.79 | -1.37 | -1.38 | -1.45 |
Diluted EPS (Rs.) | -0.09 | -0.79 | -1.37 | -1.38 | -1.45 |
Cash EPS (Rs.) | -0.07 | -0.13 | -0.06 | -0.06 | -0.14 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 1.41 | 1.50 | 2.29 | 2.94 | 4.31 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 1.41 | 1.50 | 2.29 | 2.94 | 4.31 |
Revenue From Operations / Share (Rs.) | 0.03 | 0.01 | 0.01 | 0.02 | 0.00 |
PBDIT / Share (Rs.) | -0.05 | -0.11 | -0.03 | -0.03 | -0.09 |
PBIT / Share (Rs.) | -0.06 | -0.76 | -1.34 | -1.34 | -1.40 |
PBT / Share (Rs.) | -0.08 | -0.79 | -1.37 | -1.38 | -1.45 |
Net Profit / Share (Rs.) | -0.08 | -0.79 | -1.37 | -1.38 | -1.45 |
NP After MI And SOA / Share (Rs.) | -0.08 | -0.79 | -1.37 | -1.38 | -1.45 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | -184.80 | -1592.36 | -290.36 | -153.56 | -19152.63 |
PBIT Margin (%) | -224.09 | -10578.68 | -11737.81 | -5997.29 | -295958.43 |
PBT Margin (%) | -279.05 | -10907.92 | -11999.39 | -6154.34 | -306601.70 |
Net Profit Margin (%) | -279.05 | -10907.92 | -11999.39 | -6154.34 | -306601.70 |
NP After MI And SOA Margin (%) | -279.05 | -10907.92 | -11999.39 | -6154.34 | -306601.70 |
Return on Networth / Equity (%) | -6.11 | -52.85 | -59.86 | -46.92 | -33.55 |
Return on Capital Employeed (%) | -0.40 | -4.41 | -7.37 | -7.12 | -6.91 |
Return On Assets (%) | -0.46 | -4.22 | -7.07 | -6.65 | -6.57 |
Long Term Debt / Equity (X) | 0.47 | 0.43 | 0.27 | 0.20 | 0.13 |
Total Debt / Equity (X) | 1.31 | 1.15 | 0.69 | 0.50 | 0.31 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 0.09 | 0.08 | 0.07 | 0.04 | 0.04 |
Quick Ratio (X) | 0.09 | 0.08 | 0.06 | 0.04 | 0.04 |
Inventory Turnover Ratio (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | -3.36 | -4.84 | -1.11 | -0.97 | -1.80 |
Interest Coverage Ratio (Post Tax) (%) | -4.08 | -32.13 | -44.87 | -38.19 | -27.81 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 75.67 | 31.98 | 39.35 | 46.01 | 33.09 |
EV / Net Operating Revenue (X) | 322.14 | 580.49 | 453.84 | 271.36 | 9256.18 |
EV / EBITDA (X) | -174.31 | -36.45 | -156.30 | -176.71 | -48.33 |
MarketCap / Net Operating Revenue (X) | 262.57 | 342.50 | 315.51 | 204.68 | 6378.80 |
Price / BV (X) | 5.76 | 1.66 | 1.57 | 1.56 | 0.69 |
Price / Net Operating Revenue (X) | 262.58 | 355.71 | 328.18 | 208.18 | 0.00 |
EarningsYield | -0.01 | -0.31 | -0.38 | -0.30 | -0.48 |